Epilepsy, a neurological disease characterized by recurrent seizures, is often associated
with a history of previous lesions in the nervous system. Impaired regulation of the activation …

Antibodies to glutamic acid decarboxylase (GAD) have been associated with several
neurological syndromes, including stiff-person syndrome, cerebellar ataxia and epilepsy …

Autoimmune encephalitides (AIE) comprise a group of inflammatory diseases of the central
nervous system (CNS), which can be further characterized by the presence of different …

Abstract Although antibodies against Glutamic Acid Decarboxylase (GAD) were originally
associated with Stiff Person Syndrome (SPS), they now denote the “GAD antibody-spectrum …

Antibodies against glutamic acid decarboxylase (GAD), originally linked to stiff person
syndrome (SPS), now denote the “GAD antibody-spectrum disorders”(GAD-SD) that also …

The glutamic acid decarboxylase 65‐kilodalton isoform (GAD65) antibody is a biomarker of
autoimmune central nervous system (CNS) disorders and, more commonly, nonneurological …

Background Accumulating data have suggested seizures occur frequently in patients with
neuronal surface antibody‐mediated autoimmune encephalitis. We aimed to evaluate …

Glutamic acid decarboxylase (GAD) antibody-associated encephalitis causes both acute
seizures and chronic epilepsy with predominantly temporal lobe onset. This condition is …

Accumulating data on patients with autoimmune encephalitis have shed light on specificities
concerning clinical presentation and outcomes, which are dependent on the antigen …

OBJECTIVE Antibodies against glutamic acid decarboxylase (GAD), originally associated
with stiff person syndrome (SPS), define the GAD antibody–spectrum disorders that also …